Lumendi shines at TxIEG 2025, a record-breaking year for the company with unprecedented interest in the DiLumen Endoluminal Interventional Platform.
LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET
“This certification is a key milestone in our global strategy to expand access to minimally invasive endoluminal procedures,” stated Peter Johann, Ph.D., Executive Chairman of Lumendi AG.